Answers are grounded in this paper and cite their sources.
Piezo1 is a non-selective mechanosensitive cation channel and an important molecular transducer of mechanotransduction, which converts extracellular mechanical forces into intracellular biochemical signals to regulate cellular function and tissue mechanical homeostasis. Increasing evidence indicates that Piezo1 is broadly expressed in many ocular organs, including the trabecular meshwork, retina, cornea, lens, and optic nerve. As a key mechanotransducer, Piezo1 converts mechanical stimuli into intracellular signals that affect intraocular pressure homeostasis, aqueous humour dynamics, retinal function, inflammatory response, and tissue remodelling. Mechanical activation of Piezo1 induces Ca 2+ influx and downstream signalling cascades (YAP/TAZ, MAPK, NF-κB, NLRP3 pathways) to regulate cellular proliferation, migration, apoptosis, and inflammation. Accumulating evidence suggests a key role of dysregulated Piezo1 signalling in the pathogenesis of several ocular diseases such as glaucoma, diabetic retinopathy, cataracts, dry eye disease, myopia, and corneal disorders. Here we explore the molecular structure and mechanogating processes of Piezo1. It details downstream signalling pathways in ocular tissues and their roles in disease progression. Moreover, this review emphasises the potential of Piezo1-directed therapy to deepen the comprehension of ocular mechanobiology and to promote the development of precision medicine approaches for vision-threatening illnesses.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: